xanthenes has been researched along with Angiogenesis, Pathologic in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.88) | 18.7374 |
| 1990's | 3 (17.65) | 18.2507 |
| 2000's | 7 (41.18) | 29.6817 |
| 2010's | 6 (35.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ito, Y; Kariya, T; Maruyama, S; Matsukawa, Y; Mizuno, M; Nishimura, H; Sakata, F; Suzuki, Y; Takei, Y | 1 |
| Cui, J; Dong, P; Feng, L; Ge, G; Huo, X; James, TD; Liu, T; Ma, X; Ning, J; Shi, L; Sun, C; Tian, X; Wang, B; Wang, C; Wang, W; Yu, Z | 1 |
| Cheng, H; Hu, RF; Li, QL; Su, JJ; Wang, YL | 1 |
| Chen, L; Fan, Y; He, S; Nie, C; Peng, A; Shao, X | 1 |
| Feuerstein, GZ; Rutkowski, JL; Wang, X; Zhan, Y; Zhao, L | 1 |
| Efferth, T; Horwedel, C; Krusche, B; Kuete, V; Ngadjui, BT; Ngameni, B; Wiench, B | 1 |
| Baguley, BC; Wilson, WR | 1 |
| Baguley, BC; Ching, LM | 1 |
| Horsman, MR; Murata, R | 1 |
| Horsman, MR; Siemann, DW | 1 |
| Holford, NH; Pruijn, FB; van Daalen, M; Wilson, WR | 1 |
| Baguley, BC; Ching, LM; Goldsmith, D; Joseph, WR; Körner, H; Sedgwick, JD | 1 |
| Begent, RH; Boden, R; Boxer, GM; Davies, L; Pedley, RB; Sharma, SK; Springer, CJ; Stribbling, SM | 1 |
| Ching, LM; Kanwar, JR; Kanwar, RK; Krissansen, GW; Pandey, S | 1 |
| Anikijenko, P; Carrasco, J; Chen, Q; Delaney, PM; King, RG; McLaren, WJ; Murr, ER; Thomas, SG; Vo, LT | 1 |
| Lepler, S; Mercer, E; Rojiani, AM; Siemann, DW | 1 |
| L'Esperance, FA | 1 |
2 review(s) available for xanthenes and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Potential of DMXAA combination therapy for solid tumors.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; Genetic Therapy; Humans; Neoplasms; Neovascularization, Pathologic; Xanthenes; Xanthones | 2002 |
Enhancement of radiation therapy by vascular targeting agents.
Topics: Animals; Antineoplastic Agents; Drug Delivery Systems; Humans; Neovascularization, Pathologic; Organophosphorus Compounds; Xanthenes; Xanthones | 2002 |
15 other study(ies) available for xanthenes and Angiogenesis, Pathologic
| Article | Year |
|---|---|
TGF-β1-VEGF-A pathway induces neoangiogenesis with peritoneal fibrosis in patients undergoing peritoneal dialysis.
Topics: Aged; Aged, 80 and over; Amino Acids; Angiogenesis Inhibitors; Animals; Cell Line; Disease Models, Animal; Female; Fibroblasts; Humans; Male; Middle Aged; Neovascularization, Pathologic; Peritoneal Dialysis; Peritoneal Fibrosis; Peritoneum; Rats, Sprague-Dawley; Receptor, Transforming Growth Factor-beta Type I; Signal Transduction; Transforming Growth Factor beta1; Vascular Endothelial Growth Factor A; Xanthenes | 2018 |
Molecular Design Strategy to Construct the Near-Infrared Fluorescent Probe for Selectively Sensing Human Cytochrome P450 2J2.
Topics: Animals; Cell Line, Tumor; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme System; Fluorescent Dyes; Humans; Leukemia; Lymphoma; Mice, Nude; Microscopy, Confocal; Microscopy, Fluorescence; Microsomes, Liver; Molecular Docking Simulation; Neovascularization, Pathologic; Protein Binding; Xanthenes | 2019 |
[Mechanism of gambogenic acid in resisting angiogenesis of lung cancer in vitro].
Topics: A549 Cells; Apoptosis; Coculture Techniques; Human Umbilical Vein Endothelial Cells; Humans; Lung Neoplasms; Neovascularization, Pathologic; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Transfection; Xanthenes | 2018 |
Isogambogenic acid inhibits tumour angiogenesis by suppressing Rho GTPases and vascular endothelial growth factor receptor 2 signalling pathway.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Cell Line; Cell Line, Tumor; Cell Proliferation; Cell Survival; Endothelium, Vascular; Female; Focal Adhesion Protein-Tyrosine Kinases; Human Umbilical Vein Endothelial Cells; Humans; Mice; Mice, Nude; Neovascularization, Pathologic; Plant Extracts; Plants, Medicinal; Proto-Oncogene Proteins c-akt; rho GTP-Binding Proteins; Signal Transduction; Terpenes; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Xanthenes; Xanthones; Xenograft Model Antitumor Assays; Zebrafish | 2013 |
Correlation between 2- and 3-dimensional assessment of tumor volume and vascular density by ultrasonography in a transgenic mouse model of mammary carcinoma.
Topics: Animals; Contrast Media; Female; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Linear Models; Mammary Neoplasms, Animal; Mice; Mice, Transgenic; Neovascularization, Pathologic; Tumor Burden; Ultrasonography; Xanthenes | 2010 |
Cytotoxicity and mode of action of four naturally occuring flavonoids from the genus Dorstenia: gancaonin Q, 4-hydroxylonchocarpin, 6-prenylapigenin, and 6,8-diprenyleriodictyol.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Phytogenic; Caspase 3; Caspase 7; Cell Cycle; Cell Survival; Chick Embryo; Chorioallantoic Membrane; Doxorubicin; Enzyme Activation; Flavones; Flavonoids; HeLa Cells; Hepatocytes; Humans; Inhibitory Concentration 50; Moraceae; Neovascularization, Pathologic; Oxazines; Plant Extracts; Quail; Structure-Activity Relationship; Time Factors; Xanthenes; Zygote | 2011 |
DMXAA: an antivascular agent with multiple host responses.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Hydroxyindoleacetic Acid; Mice; Mice, Inbred C57BL; Mice, Knockout; Models, Biological; Models, Chemical; Necrosis; Neoplasm Transplantation; Neovascularization, Pathologic; Nitric Oxide; Receptors, Tumor Necrosis Factor; Serotonin; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Xanthenes; Xanthones | 2002 |
Combination of vascular targeting agents with thermal or radiation therapy.
Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Dose-Response Relationship, Radiation; Flavonoids; Hyperthermia, Induced; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Neoplasms; Neovascularization, Pathologic; Stilbenes; Temperature; Time Factors; Tumor Cells, Cultured; X-Rays; Xanthenes; Xanthones | 2002 |
Mechanisms of enhancement of the antitumour activity of melphalan by the tumour-blood-flow inhibitor 5,6-dimethylxanthenone-4-acetic acid.
Topics: Animals; Antineoplastic Agents, Alkylating; Cell Hypoxia; Drug Synergism; Female; Mammary Neoplasms, Experimental; Melphalan; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Neovascularization, Pathologic; Xanthenes; Xanthones | 1997 |
Induction of intratumoral tumor necrosis factor (TNF) synthesis and hemorrhagic necrosis by 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in TNF knockout mice.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Colonic Neoplasms; Gene Expression Regulation, Neoplastic; Hemorrhage; Mice; Mice, Inbred C57BL; Mice, Knockout; Necrosis; Neoplasm Proteins; Neovascularization, Pathologic; RNA, Messenger; RNA, Neoplasm; Tumor Necrosis Factor-alpha; Xanthenes; Xanthones | 1999 |
Enhancement of antibody-directed enzyme prodrug therapy in colorectal xenografts by an antivascular agent.
Topics: Animals; Antineoplastic Agents; Carcinoembryonic Antigen; Colorectal Neoplasms; Female; gamma-Glutamyl Hydrolase; Glutamates; Humans; Immunoconjugates; Immunoglobulin Fab Fragments; Mice; Mice, Nude; Neoplasm Transplantation; Neovascularization, Pathologic; Nitrogen Mustard Compounds; Prodrugs; Transplantation, Heterologous; Xanthenes; Xanthones | 1999 |
Vascular attack by 5,6-dimethylxanthenone-4-acetic acid combined with B7.1 (CD80)-mediated immunotherapy overcomes immune resistance and leads to the eradication of large tumors and multiple tumor foci.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; B7-1 Antigen; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Combined Modality Therapy; Female; Flavonoids; Gene Dosage; Genetic Therapy; Genetic Vectors; Immunotherapy; Killer Cells, Natural; Lymphocyte Subsets; Lymphoma; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; T-Lymphocytes, Cytotoxic; Thymus Neoplasms; Xanthenes; Xanthones | 2001 |
In vivo detection of small subsurface melanomas in athymic mice using noninvasive fiber optic confocal imaging.
Topics: Animals; Fiber Optic Technology; Fluorescent Dyes; Humans; Melanoma; Mice; Mice, Inbred BALB C; Mice, Nude; Microscopy, Confocal; Neoplasm Transplantation; Neovascularization, Pathologic; Optical Fibers; Skin; Skin Neoplasms; Tumor Cells, Cultured; Xanthenes | 2001 |
Vascular targeting agents enhance chemotherapeutic agent activities in solid tumor therapy.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Blood Vessels; Cisplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Synergism; Female; Humans; Mice; Mice, Inbred C3H; Mice, Nude; Necrosis; Neovascularization, Pathologic; Sarcoma, Experimental; Stilbenes; Tumor Cells, Cultured; Xanthenes; Xanthones | 2002 |
Trans-spectral organic dye laser photocoagulation.
Topics: Angiomatosis; Choroid Neoplasms; Coloring Agents; Diabetic Retinopathy; Eye Neoplasms; Fluorescein Angiography; Hemangioma; Humans; Laser Therapy; Light Coagulation; Macular Degeneration; Neovascularization, Pathologic; Retinal Diseases; Retinal Vein; Retinal Vessels; Rhodamines; Staining and Labeling; Xanthenes | 1985 |